Trump signs executive actions changing metal tariffs and imposing new pharmaceutical tariffs
The facts
- Trump signed executive actions on Thursday that changed tariff policy for both imported metals and pharmaceuticals.
- The pharmaceutical measures allow tariffs of up to 100% on certain imported patented or branded drugs and related ingredients.
- The new pharmaceutical tariffs are aimed at pushing drugmakers to move manufacturing to the United States.
- Drug companies that reach agreements with the administration can receive lower tariff rates or avoid the tariffs altogether.
- Companies that are building or committing to U.S. production but do not fully qualify for exemption can face a lower tariff rate than 100%, including a 20% rate under the new framework.
- Generic medicines are exempt from the new pharmaceutical tariffs for now.
- The administration said the metal tariff changes were intended to simplify the system and address complaints that the previous rules were overly burdensome.
Context
Which medicines are affected by the new pharmaceutical tariffs?
The new policy targets certain patented or branded drugs and related ingredients, while generic medicines are exempt for now BBC,Guardian,Hindustan Times.
How can drugmakers avoid the 100% tariff?
The administration said companies can reduce or avoid the tariff by striking agreements with the government, including commitments to move production to the United States and, in some cases, to meet administration pricing terms BBC,Daily Mail,USA Today.
The receipts — 100 sources
Wire services (6)
Other coverage (94)
A news briefing built to show both sides.
The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.